Literature DB >> 32880247

Management of Candida auris outbreak in a tertiary-care setting in Saudi Arabia.

Majid M Alshamrani1,2, Aiman El-Saed1,2,3, Azzam Mohammed1, Majed F Alghoribi2,4, Sameera M Al Johani2,5, Harold Cabanalan1, Hanan H Balkhy6.   

Abstract

OBJECTIVE: To describe local experience in managing an outbreak of Candida auris in a tertiary-care setting.
METHODS: In response to emerging Candida auris, an outbreak investigation was conducted at our hospital between March 2018 and June 2019. Once a patient was confirmed to have Candida auris, screening of exposed patients and healthcare workers (HCWs) was conducted. Postexposure screening included those who had had direct contact with or shared the same unit or ward with a laboratory-confirmed case. In response to the increasing number of cases, new infection control measures were implemented.
RESULTS: In total, 23 primary patients were detected over 15 months. Postexposure screening identified 11 more cases, and all were patients. Furthermore, ~28.6% of patients probably caught infection in another hospital or in the community. Infection control measures were strictly implemented including hand hygiene, personal protective equipment, patient hygiene, environmental cleaning, cohorting of patients and HCWs, and avoiding the sharing of equipment. The wave reached a peak in April 2019, followed by a sharp decrease in May 2019 and complete clearance in June 2019. The case patients were equally distributed between intensive care units (51.4%) and wards (48.6%). More infections (62.9%) occurred than colonizations (37.1%). Urinary tract infection (42.9%) and candidemia (17.1%) were the main infections. In total, 7 patients (20.0%) died during hospitalization; among them, 6 (17.1%) died within 30 days of diagnosis.
CONCLUSIONS: Active screening of exposed patients followed by strict infection control measures, including environmental cleaning, was successful in ending the outbreak. Preventing future outbreaks is challenging due to outside sources of infection and environmental resistance.

Entities:  

Year:  2020        PMID: 32880247     DOI: 10.1017/ice.2020.414

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  6 in total

1.  Population genomic analyses reveal evidence for limited recombination in the superbug Candida auris in nature.

Authors:  Yue Wang; Jianping Xu
Journal:  Comput Struct Biotechnol J       Date:  2022-06-16       Impact factor: 6.155

2.  COVID-19 and C. auris: A Case-Control Study from a Tertiary Care Center in Lebanon.

Authors:  Fatima Allaw; Sara F Haddad; Nabih Habib; Pamela Moukarzel; Nour Sabiha Naji; Zeina A Kanafani; Ahmad Ibrahim; Nada Kara Zahreddine; Nikolaos Spernovasilis; Garyphallia Poulakou; Souha S Kanj
Journal:  Microorganisms       Date:  2022-05-11

Review 3.  Candida auris: Epidemiology, Diagnosis, Pathogenesis, Antifungal Susceptibility, and Infection Control Measures to Combat the Spread of Infections in Healthcare Facilities.

Authors:  Suhail Ahmad; Wadha Alfouzan
Journal:  Microorganisms       Date:  2021-04-11

4.  Molecular Epidemiology of Candida Auris Outbreak in a Major Secondary-Care Hospital in Kuwait.

Authors:  Wadha Alfouzan; Suhail Ahmad; Rita Dhar; Mohammad Asadzadeh; Noura Almerdasi; Naglaa M Abdo; Leena Joseph; Theun de Groot; Walid Q Alali; Ziauddin Khan; Jacques F Meis; Mohammad R Al-Rashidi
Journal:  J Fungi (Basel)       Date:  2020-11-21

5.  A Case Report of a Candida auris Infection in Saudi Arabia.

Authors:  Mais B Alashqar; Lulwah Alabdan; Mohammad Khan; Abdul Hakim Almakadma; Sami Almustanyir
Journal:  Cureus       Date:  2021-05-25

6.  Genomic Epidemiology of Candida auris in Qatar Reveals Hospital Transmission Dynamics and a South Asian Origin.

Authors:  Husam Salah; Sathyavathi Sundararaju; Lamya Dalil; Sarah Salameh; Walid Al-Wali; Patrick Tang; Fatma Ben Abid; Clement K M Tsui
Journal:  J Fungi (Basel)       Date:  2021-03-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.